LARNAISHA WILLIAMS: Open Payments
NPI 1760054480 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 65 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,182 · 2025 $1,462
Food & beverage: $1,462
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $318 |
| Vanda Pharmaceuticals Inc. | 8 | $280 |
| Alkermes, Inc. | 10 | $199 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $170 |
| Corium, LLC | 10 | $131 |
| Axsome Therapeutics, Inc. | 3 | $87 |
| ABBVIE INC. | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
Products named: FANAPT, ARISTADA, CAPLYTA, REXULTI, Azstarys, Auvelity, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across LA — which companies pay providers there.
